-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Xetra FrankfurtEURISIN US717081ER06-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009USDSymbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10EURSymbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61EURSymbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06EURSymbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082EURSymbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31EURSymbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88EURSymbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23EURSymbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02EURSymbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357EURSymbol PFE
-
PfizerBörse Xetra FrankfurtEURISIN US717081EY56
-
PfizerBörse Börse MünchenEURISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22SEKSymbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52MXNSymbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresUSDISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US717081DH33
-
PfizerBörse BUEUSDISIN US717081EV18
-
ISIN US717081EX73EURSymbol PFE
-
PfizerBörse OMXSSEKISIN US7170811035
-
EURISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
ISIN US717081ER06
Symbol PFE
Währung
EUR
Börse
Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname
Pfizer Inc
Marktkapitalisierung
197.500.079.920 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Mitarbeiter
83.400 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Anzahl Aktien
5.558.396.599
KGV
18.68 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
1.790 News & Informationen zur Pfizer Aktie
Canal Insurance CO Buys GlaxoSmithKline PLC, AeroVironment Inc, Barrick Gold Corp, Sells Raytheon Technologies Corp, CVS Health Corp, Pfizer Inc
GuruFocus Article or News written by insider and the topic is about:
Trillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact th
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Trillium Therapeutics Inc. to Pfizer Inc. for $18.50 per share in cash is fair to Trillium… | August 23, 2021
U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine
The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine that had earned emergency-use authorization in December,…
Pfizer to pay $2.26 billion for cancer treatment developer Trillium
Cancer treatments brought in $10.9 billion in revenue last year, and Pfizer’s oncology products include treatments for breast, colorectal, blood and lung cancers.
Wall Street rebounds as banks, energy surge
Wall Street’s main indexes rose on Monday, with banks and energy shares leading the gains, as investors returned to riskier assets after a sharp selloff last…
Jackson Hole Goes Virtual: Powell Speech On Friday Could Set Tone On Policy
The fresh air of Wyoming beckons this week, but it will have to be from a distance as Fed Chairman Jerome Powell and company prepare for a virtual Jackson …
Pfizer-BioNTech Vaccine Gains FDA Approval, 7 Things To Know Right Now
Pfizer to buy Canadian drug developer Trillium Therapeutics for $2.2B
Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies.
Pfizer to pay $2.26B for cancer treatment developer Trillium
Pfizer is spending more than $2 billion in cash to buy another drugmaker focused on potential cancer treatments
Pfizer/BioNTech COVID-19 vaccine wins full FDA approval for COVID-19 vaccine (NYSE:PFE)
The FDA granted the full approval for the COVID-19 vaccine developed by Pfizer <> and BioNTech <>.In December, the two-dose vaccine became the first COVID-19 shot to receive…
Stocks rally as investors eye Fed's Jackson Hole event
Stocks rallied as investors eyed a key Federal Reserve event that could lay the framework to begin the central bank's tapering process.
Doctors question the optics and the scientific rationale behind the plan for COVID-19 booster shots in the U.S.
The decision to give out extra doses of Moderna and Pfizer’s COVID-19 vaccines pits federal health officials who say the shots may not protect people from…
Pfizer to buy oncology biotech in $2.3bn deal
US drugmaker to buy all shares of Trillium Therapeutics as part of investment in blood cancers
Trillium Therapeutics : VOTING SUPPORT AGREEMENT (Form 8-K)
VOTING SUPPORT AGREEMENT
THIS AGREEMENT is made as of the 20th day of August, 2021.
BETWEEN:
PF ARGENTUM ACQUISITION ULC, a corporation formed… | August 23, 2021
Stock futures rally as investors eye Fed's Jackson Hole event
Stock futures rallied as investors eyed a key Federal Reserve event that could lay the framework to begin the central bank's tapering process.
Ardern further extends lockdown as New Zealand outbreak grows
New Zealand Prime Minister Jacinda Ardern further extended a strict, nationwide lockdown as an outbreak of the Delta strain of coronavirus continues to grow. The entire country will remain at Level 4 restrictions, the highest level of lockdown, until midnight August 27, Ardern told a news conference Monday in Wellington.…
Trillium Therapeutics shares soar on Pfizer’s $2.26B deal
Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
25 Stocks Moving in Monday's Pre-Market Session
Gainers Greenpro Capital Corp. (NASDAQ:GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the c…
Bitcoin, Pfizer COVID-19 Vaccine, Dogecoin, NFT And Disney: 5 Headlines From Weekend You May Have Missed
There has been some exciting news from the biotech, cryptocurrency and corporate sectors that investors may have missed over the weekend. Here is a quick …
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises Over 3%
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones surged more than 200 points in the previous sessio…
5 Stocks To Watch For August 23, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Palo Alto Networks Inc (NYSE:PANW) to report quarterly earnings …
European Stocks Higher; PMIs Point to Slowing Recovery By Investing.com
European Stocks Higher; PMIs Point to Slowing Recovery
European stocks climb after bruising week By Reuters
European stocks climb after bruising week
Mounting evidence that delta variant is winning – case for boosters is building
The rollout of a third dose of Covid vaccine has sparked debate on ethical and political grounds, since a large swath of the human population is yet to receive…
Global Equities: Playing Defense
Stocks Analysis by Mike Zaccardi, CFA, CMT covering: S&P 500, US Small Cap 2000, Merck & Company Inc, Pfizer Inc. Read Mike Zaccardi, CFA, CMT's latest article on Investing.com
Israel finds COVID-19 vaccine booster significantly lowers infection risk By Reuters
Israel finds COVID-19 vaccine booster significantly lowers infection risk
Beating back Delta variant will take extra Covid shot for privileged few
The most-infectious coronavirus variant to emerge so far is in a race with the human immune system, and there’s mounting evidence that delta is winning — at least initially
The case for a booster shot is building, even if privileged few get it
Read more about The case for a booster shot is building, even if privileged few get it on Business Standard. The reason is delta. The most-infectious coronavirus variant to emerge so far is in a race with the human immune system, and there's mounting evidence that delta is winning
U.S. administers 361.7 million doses of COVID-19 vaccines -CDC By Reuters
U.S. administers 361.7 million doses of COVID-19 vaccines -CDC
The Latest Barron's Picks And Pans: Facebook, Jefferies, Palantir, Spotify And More
This weekend's Barron's cover story examines the long-term prospects for big tech companies currently in the sights of regulators and law…
World may never reach herd immunity against Covid-19
As Covid-19 surged last year, governments worldwide touted the hope of “herd immunity,” a promised land where the virus stopped spreading exponentially because enough people were protected against it. That’s now looking like a fantasy. The thinking was that the pandemic would ebb and then mostly fade once a chunk…
Pfizer, Netflix, Amazon.com: Stocks That Defined the Week
Here are seven major companies whose stocks moved on the week’s news.
FDA is expected to give full approval of Pfizer COVID-19 vaccine next week
The Food and Drug Administration is expected next week to grant full approval of the COVID-19 vaccine from Pfizer Inc. and partner BioNTech SE, according to…
Factbox-Major U.S. companies making masks, vaccines mandatory
The resurgence of COVID-19 cases in the United States due to the Delta variant and the new guidance from the U.S. Centers for Disease Control and Prevention that requires fully vaccinated… | August 20, 2021
U.S. FDA aims to give full approval to Pfizer vaccine on Monday
U.S. FDA aims to give full approval to Pfizer vaccine on Monday – NYT
Pfizer/BioNTech COVID-19 vaccine set to win full FDA approval on Monday – NYT (NYSE:PFE)
The FDA is planning to grant the full approval for the COVID-19 vaccine developed by Pfizer (PFE)/ BioNTech (BNTX) on Monday, The New York Times reported citing people familiar with…
As Covid-19 Boosters Loom, Pfizer and Moderna Expect to See Billions More in Sales
Vaccine makers Pfizer Inc. and Moderna Inc. are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant push demand, and the companies raise prices in the U.S. and elsewhere.
Pfizer wins EU marketing authorization for XELJANZ against arthritic conditions (NYSE:PFE)
Pfizer (PFE) announced that the European Commission ((EC)) has approved XELJANZ (tofacitinib) for the treatment of active polyarticular juvenile idiopathic arthritis ((JIA))…
Pfizer : XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Pfizer Inc. announced today that the European Commission has approved XELJANZ® for the treatment of active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis in… | August 20, 2021
Moderna mandates COVID-19 vaccination for U.S. employees
Moderna Inc said on Friday it will require COVID-19 vaccination for all its employees in the United States from October.